{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Substituted pyridines as irreversible inhibitors of menin-MLL interaction", "item": "https://www.patentleaderboard.com/patent/11702421"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyridines as irreversible inhibitors of menin-MLL interaction

Substituted pyridines as irreversible inhibitors of menin-MLL interaction

US Patent 11702421 · Granted Jul 18, 2023

Estimated economic value: $24,056,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of menin-MLL interaction2025
Inhibitors of menin-MLL interaction2025
Inhibitors of menin-MLL interaction2025
Inhibitors of menin-MLL interaction2025
Inhibitors of menin-MLL interaction2025
Inhibitors of menin-MLL interaction2025
Inhibitors of menin-MLL interaction2025
Covalent inhibitors of menin-MLL interaction for diabetes mellitus2025
Methods and compositions for purification or isolation of microvesicles and exos2024
CD16a binding agents and uses thereof2024
Substituted pyridines as irreversible inhibitors of menin-MLL interaction2024
Substituted pyridines as irreversible inhibitors of menin-MLL interaction2024